Zhongbao Pharma

Zhejiang Zhongbao Pharmaceutical is a Chinese pharmaceutical company specializing in the research, development, and large-scale manufacturing of intravenous (IV) solutions and generic medications. Based in Quzhou, the company operates high-standard GMP facilities producing large-volume parenterals, including glucose and sodium chloride injections. Their product portfolio also includes various anti-infective, cardiovascular, and respiratory treatments in injectable formats. Zhongbao Pharma serves as a key supplier in the domestic Chinese healthcare market, focusing on essential medicines and hospital-grade products. The company has established a significant presence in the regional market through its commitment to quality control and efficient production of high-demand clinical staples. It was previously listed on China's New Third Board, reflecting its established position in the national pharmaceutical landscape.